309. Progressive myoclonus epilepsy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 11 / Drugs : 15 - (DrugBank : 2) / Drug target genes : 4 - Drug target pathways : 9
Drugs and their primary sponsors and trial info
(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide
UCB S.A.
2006 - EUCTR2006-001536-46-FR Finland;France;
2006 - EUCTR2006-001536-46-FI Finland;France;
(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide
UCB Pharma S.A.
2006 - EUCTR2006-000169-12-SE Finland;France;Italy;Netherlands;Sweden;
UCB S.A.
2006 Phase 3 EUCTR2006-000169-12-FR Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-000169-12-NL Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-000169-12-FI Finland;France;Italy;Netherlands;Sweden;
BRV
UCB Pharma
2006 Phase 3 NCT00368251 Canada;Finland;Former Serbia and Montenegro;France;Israel;Russian Federation;Serbia;Tunisia;United States;
Brivaracetam
UCB Pharma S.A.
2006 - EUCTR2006-000169-12-SE Finland;France;Italy;Netherlands;Sweden;
UCB Pharma SA
2006 Phase 3 NCT00357669 Finland;France;Italy;Netherlands;Réunion;Sweden;Tunisia;
UCB S.A.
2006 Phase 3 EUCTR2006-000169-12-FR Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-001536-46-FR Finland;France;
2006 - EUCTR2006-001536-46-FI Finland;France;
2006 - EUCTR2006-000169-12-NL Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-000169-12-FI Finland;France;Italy;Netherlands;Sweden;
Intravenous immunoglobulin
Azienda Socio Sanitaria Territoriale di Mantova
2015 Phase 3 NCT03351569 -
Requip
Department of Neurology, Turku University Hospital
2007 - EUCTR2007-003210-33-FI Finland;
Ucb 34714
UCB Pharma S.A.
2006 - EUCTR2006-000169-12-SE Finland;France;Italy;Netherlands;Sweden;
UCB S.A.
2006 Phase 3 EUCTR2006-000169-12-FR Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-001536-46-FR Finland;France;
2006 - EUCTR2006-001536-46-FI Finland;France;
2006 - EUCTR2006-000169-12-NL Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-000169-12-FI Finland;France;Italy;Netherlands;Sweden;
UCB S.A.
2006 - EUCTR2006-001536-46-FR Finland;France;
2006 - EUCTR2006-001536-46-FI Finland;France;
(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide
UCB Pharma S.A.
2006 - EUCTR2006-000169-12-SE Finland;France;Italy;Netherlands;Sweden;
UCB S.A.
2006 Phase 3 EUCTR2006-000169-12-FR Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-000169-12-NL Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-000169-12-FI Finland;France;Italy;Netherlands;Sweden;
BRV
UCB Pharma
2006 Phase 3 NCT00368251 Canada;Finland;Former Serbia and Montenegro;France;Israel;Russian Federation;Serbia;Tunisia;United States;
Brivaracetam
UCB Pharma S.A.
2006 - EUCTR2006-000169-12-SE Finland;France;Italy;Netherlands;Sweden;
UCB Pharma SA
2006 Phase 3 NCT00357669 Finland;France;Italy;Netherlands;Réunion;Sweden;Tunisia;
UCB S.A.
2006 Phase 3 EUCTR2006-000169-12-FR Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-001536-46-FR Finland;France;
2006 - EUCTR2006-001536-46-FI Finland;France;
2006 - EUCTR2006-000169-12-NL Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-000169-12-FI Finland;France;Italy;Netherlands;Sweden;
Intravenous immunoglobulin
Azienda Socio Sanitaria Territoriale di Mantova
2015 Phase 3 NCT03351569 -
Requip
Department of Neurology, Turku University Hospital
2007 - EUCTR2007-003210-33-FI Finland;
Ucb 34714
UCB Pharma S.A.
2006 - EUCTR2006-000169-12-SE Finland;France;Italy;Netherlands;Sweden;
UCB S.A.
2006 Phase 3 EUCTR2006-000169-12-FR Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-001536-46-FR Finland;France;
2006 - EUCTR2006-001536-46-FI Finland;France;
2006 - EUCTR2006-000169-12-NL Finland;France;Italy;Netherlands;Sweden;
2006 - EUCTR2006-000169-12-FI Finland;France;Italy;Netherlands;Sweden;